Magnesium Supplementation for Deficiency
For magnesium deficiency, organic magnesium salts (aspartate, citrate, lactate) are recommended due to their higher bioavailability compared to magnesium oxide/hydroxide, with a target serum level >0.6 mmol/L (>1.5 mg/dL). 1
Diagnosis of Magnesium Deficiency
Magnesium deficiency is defined as serum magnesium <1.8 mg/dL (<0.74 mmol/L)
- Mild deficiency: 1.3-1.7 mg/dL (0.54-0.70 mmol/L)
- Severe deficiency: <1.2 mg/dL (<0.5 mmol/L)
Note: Serum magnesium may be normal despite intracellular magnesium depletion, as less than 1% of magnesium stores are in the blood 2
Treatment Algorithm Based on Severity
Severe Hypomagnesemia (Emergency Situations)
IV Administration:
- For life-threatening conditions (e.g., torsades de pointes, seizures):
- 1-2g IV bolus of magnesium sulfate diluted in 10mL D5W 1
- For severe deficiency without immediate threat:
- For life-threatening conditions (e.g., torsades de pointes, seizures):
Monitoring during IV administration:
Mild to Moderate Hypomagnesemia
Oral Supplementation Options:
Administration Strategy:
Special Considerations
Concurrent Electrolyte Abnormalities
- Hypokalemia and hypocalcemia often coexist with hypomagnesemia
- Refractory hypokalemia may not respond to potassium supplementation until magnesium is repleted 1
- Monitor and correct all electrolyte abnormalities concurrently
Renal Considerations
- In patients with renal insufficiency, reduce dosage and monitor serum levels more frequently 3
- Maximum dosage in severe renal insufficiency: 20 grams/48 hours 3
Dietary Recommendations
- Increase intake of magnesium-rich foods (green leafy vegetables, nuts, seeds, whole grains)
- Consider limiting high-fat foods, particularly animal fats 2
Monitoring and Follow-up
- For oral supplementation: Recheck magnesium levels after 1-2 weeks of therapy
- For IV supplementation: Monitor levels every 4-6 hours during acute correction
- Continue supplementation until target level >0.6 mmol/L (>1.5 mg/dL) is achieved 1
- Regular monitoring is essential in patients with ongoing risk factors for magnesium deficiency
Cautions
- Avoid magnesium supplementation in patients with severe renal impairment (creatinine clearance <20 mg/dL) due to risk of hypermagnesemia 2
- Continuous maternal administration of magnesium sulfate in pregnancy beyond 5-7 days can cause fetal abnormalities 3
- Diarrhea is a common side effect of oral magnesium supplementation and may limit dosing 2
By following this structured approach to magnesium supplementation based on deficiency severity, clinicians can effectively restore magnesium levels while minimizing adverse effects.